Short Bio

Dr. David Granville is a Professor and Associate Dean, Research in the UBC Faculty of Medicine. He is also the Executive Director of the Vancouver Coastal Health Research Institute, the largest hospital-based research institute in Western Canada. He is a Principal Investigator at the ICORD Centre, the UBC Centre for Heart Lung Innovation and is the Director of the BC Professional Firefighters’ Burn and Wound Healing Research Group. Dr. Granville previously worked at QLT, Inc. (1994-2001) where his R&D studies supported the approval of Visudyne® to be used as the first treatment for macular degeneration, the leading cause of blindness in the elderly. In 1999 Visudyne® was approved by the FDA resulting in the largest ophthalmic product release in history. Dr. Granville’s research is referred to on the drug label for Visudyne®. In 2001, Dr. Granville moved to Scripps where he discovered a novel therapeutic target for attenuating ischemic heart injury related to myocardial infarction and transplantation, which led to the formation of Radical Therapeutix (San Diego, CA). He was recruited back to UBC as an Assistant Professor, Canada Research Chair and MSFHR Scholar to work at the UBC Centre for Heart Lung Innovation (2003-2016). In 2016 he relocated to the ICORD Centre/VCHRI/UBC. Dr. Granville has received numerous awards including a Michael Smith Foundation for Health Research Scholar Award, Canada Research Chair, Canada Top 40 Under 40 Award, Business in Vancouver Top Forty Under 40, Canadian Association of Pathology Scientist Award, UBC Outstanding Young Alumnus Award, SFU Academic Alumnus Award, and was a runner-up for the American Heart Association Louis and Arnold Katz Basic Science Prize. He is also a Scholar of the Royal Society of Canada and a Fellow of the American Heart Association. His current research is focused on mechanisms of tissue injury, inflammation and repair and how aging and dysregulated inflammation affect tissue integrity, repair and remodelling. His recent research has led to the formation of the UBC-spin-off company, viDA Therapeutics of which he is a co-Founder and Chief Scientific Officer.

• Executive Director, Vancouver Coastal Health Research Institute (VCHRI)
• Associate Dean, Research – VCHRI, Faculty of Medicine, UBC
• Associate Director, BC Professional Firefighters’ Burn and Wound Healing Research Laboratory, Division of Plastic Surgery, Department of Surgery, UBC
• Principal Investigator, UBC ICORD
• Principal Investigator, UBC Centre for Heart Lung Innovation, St. Paul’s Hospital
• Associate Member, Department of Surgery, UBC
• Affiliated Member, CIHR Skin Research Training Centre, UBC
• Adjunct Professor, Institute of Molecular Biology and Biochemistry, Simon Fraser University
• Co-Founder and Chief Scientific Officer, viDA Therapeutics Inc.